| Reference |
|---|
Sekar P, Rajagopalan S, Shabani E, Kanjee U, Schureck M, Arora G, et al. NK cell-induced damage to P.falciparum-infected erythrocytes requires ligand-specific recognition and releases parasitophorous vacuoles that are phagocytosed by monocytes in the presence of immune IgG. PLoS Pathog. 2023;19:e1011585 pubmed publisher |
Ryan T, Hooftman A, Rehill A, Johansen M, Brien E, Toller Kawahisa J, et al. Dimethyl fumarate and 4-octyl itaconate are anticoagulants that suppress Tissue Factor in macrophages via inhibition of Type I Interferon. Nat Commun. 2023;14:3513 pubmed publisher |
Holay N, Kennedy B, Murphy J, Konda P, Giacomantonio M, Brauer Chapin T, et al. After virus exposure, early bystander naïve CD8 T cell activation relies on NAD+ salvage metabolism. Front Immunol. 2022;13:1047661 pubmed publisher |
Wagner A, Weindel C, West K, Scott H, Watson R, Patrick K. SRSF6 balances mitochondrial-driven innate immune outcomes through alternative splicing of BAX. elife. 2022;11: pubmed publisher |
Strine M, Alfajaro M, Graziano V, Song J, Hsieh L, Hill R, et al. Tuft-cell-intrinsic and -extrinsic mediators of norovirus tropism regulate viral immunity. Cell Rep. 2022;41:111593 pubmed publisher |
Kalliara E, Kardynska M, Bagnall J, Spiller D, M xfc ller W, Rückerl D, et al. Post-transcriptional regulatory feedback encodes JAK-STAT signal memory of interferon stimulation. Front Immunol. 2022;13:947213 pubmed publisher |
Vergato C, Doshi K, Roblyer D, Waxman D. Type-I interferon signaling is essential for robust metronomic chemo-immunogenic tumor regression in murine breast cancer. Cancer Res Commun. 2022;2:246-257 pubmed publisher |
Kanno T, Miyako K, Nakajima T, Yokoyama S, Sasamoto S, Asou H, et al. SCD2-mediated cooperative activation of IRF3-IRF9 regulatory circuit controls type I interferon transcriptome in CD4+ T cells. Front Immunol. 2022;13:904875 pubmed publisher |
Eissa I, Mukoyama N, Abdelmoneim M, Naoe Y, Matsumura S, Bustos Villalobos I, et al. Oncolytic herpes simplex virus HF10 (canerpaturev) promotes accumulation of CD8+ PD-1- tumor-infiltrating T cells in PD-L1-enriched tumor microenvironment. Int J Cancer. 2021;149:214-227 pubmed publisher |
Hsieh W, Zhou Q, York A, Williams K, Scumpia P, Kronenberger E, et al. Toll-Like Receptors Induce Signal-Specific Reprogramming of the Macrophage Lipidome. Cell Metab. 2020;32:128-143.e5 pubmed publisher |
Zhou Q, Chi X, Lee M, Hsieh W, Mkrtchyan J, Feng A, et al. Interferon-mediated reprogramming of membrane cholesterol to evade bacterial toxins. Nat Immunol. 2020;21:746-755 pubmed publisher |
Huerga Encabo H, Traveset L, Argilaguet J, Angulo A, Nistal Villán E, Jaiswal R, et al. The transcription factor NFAT5 limits infection-induced type I interferon responses. J Exp Med. 2020;217: pubmed publisher |
Du B, Waxman D. Medium dose intermittent cyclophosphamide induces immunogenic cell death and cancer cell autonomous type I interferon production in glioma models. Cancer Lett. 2020;470:170-180 pubmed publisher |
Chen Y, Lee T, Tzeng S. Reduced DAXX Expression Is Associated with Reduced CD24 Expression in Colorectal Cancer. Cells. 2019;8: pubmed publisher |
Luteijn R, Zaver S, Gowen B, Wyman S, Garelis N, Onia L, et al. SLC19A1 transports immunoreactive cyclic dinucleotides. Nature. 2019;573:434-438 pubmed publisher |
Yang L, Ding J. MEK1/2 Inhibitors Unlock the Constrained Interferon Response in Macrophages Through IRF1 Signaling. Front Immunol. 2019;10:2020 pubmed publisher |
Hatchwell L, Collison A, Girkin J, Parsons K, Li J, Zhang J, et al. Toll-like receptor 7 governs interferon and inflammatory responses to rhinovirus and is suppressed by IL-5-induced lung eosinophilia. Thorax. 2015;70:854-61 pubmed publisher |
